Lack of correlation for anti-β1 autoantibodies and cardioelectric disorders in chagas cardiomyopathy

Analia G. Paolucci, Section of Cardiovascular Genomic, Division of Cardiology, Hospital General José María Ramos Mejía, Buenos Aires, Argentina
Dhruv Krishnan, Department of Medicine, Kingston Health Sciences Centre, Kingston, Ontario, Canada
Mario B. Principato, Section of Cardiovascular Genomic, Division of Cardiology, Hospital General José María Ramos Mejía, Buenos Aires, Argentina
María A. Von-Wulffen, Section of Cardiovascular Genomic, Division of Cardiology, Hospital General José María Ramos Mejía, Buenos Aires, Argentina
Justo Carbajales, Section of Cardiovascular Genomic, Division of Cardiology, Hospital General José María Ramos Mejía, Buenos Aires, Argentina
Adrian Baranchuk, Department of Medicine, Kingston Health Sciences Centre, Kingston, Ontario, Canada

Chagas’ disease, caused by the parasite Trypanosoma cruzi, is one of the most pervasive endemic infections in Latin America, currently affecting approximately 7 million people¹.